ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 79 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,356 | -99.8% | 400,000 | 0.0% | 0.13% | +140.0% |
| Q3 2022 | $1,280,000 | -28.6% | 400,000 | 0.0% | 0.06% | -42.7% |
| Q2 2022 | $1,792,000 | -16.1% | 400,000 | 0.0% | 0.10% | +7.9% |
| Q1 2022 | $2,136,000 | -63.7% | 400,000 | 0.0% | 0.09% | -44.4% |
| Q4 2021 | $5,880,000 | -29.7% | 400,000 | 0.0% | 0.16% | -14.4% |
| Q3 2021 | $8,364,000 | +18.2% | 400,000 | 0.0% | 0.19% | +29.9% |
| Q2 2021 | $7,076,000 | +188.8% | 400,000 | +300.0% | 0.14% | +234.9% |
| Q1 2021 | $2,450,000 | -27.6% | 100,000 | 0.0% | 0.04% | -41.1% |
| Q4 2020 | $3,385,000 | -5.0% | 100,000 | -29.8% | 0.07% | -16.1% |
| Q3 2020 | $3,564,000 | -29.6% | 142,500 | -5.0% | 0.09% | -38.7% |
| Q2 2020 | $5,060,000 | – | 150,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |